Pulmonary Arterial Denervation in Patients With Pulmonary Hypertension Associated With the Left Heart Failure

NACompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

August 8, 2014

Primary Completion Date

June 16, 2018

Study Completion Date

December 30, 2018

Conditions
Pulmonary Hypertension
Interventions
PROCEDURE

Pulmonary arterial denervation

Contrast pulmonary artery (PA) angiography was performed to localize the pulmonary artery bifurcation level and calculate the PA diameter.Once the anatomy was deemed acceptable, the radiofrequency ablation catheter was introduced into the distal bifurcation area of the main PA.This was then maneuvered within the PA to allow energy delivery to ensure that the electrodes were tightly in contact with the endovascular surface. About two to three ablations at 1-15 W for 240 seconds each point were performed in the distal bifurcation area of the main PA.

DRUG

Standard treatment

Patients in the standard treatment group will take their baseline anti-heart failure medications at the original doses, without any changes except when medically required.The anti-heart failure drugs treatment is consistent in both arms.Patients in the standard treatment group will take one or combination of the following target drugs: endothelin receptor antagonist, 5'-PDE and prostacyclin. On the other hand, patients in the PADN group do not take any of the target drugs mentioned above.

Trial Locations (1)

210006

Nanjing First Hospital, Nanjing

All Listed Sponsors
lead

Nanjing First Hospital, Nanjing Medical University

OTHER

NCT02220335 - Pulmonary Arterial Denervation in Patients With Pulmonary Hypertension Associated With the Left Heart Failure | Biotech Hunter | Biotech Hunter